News Digest / Ticker: XLO

Ticker: XLO

09:16am, Thursday, Aug 14, 2025

Xilio boosts liquidity via Gilead/AbbVie deals but flags going-concern, warrants add volatility

Xilio Therapeutics, Inc. (NASDAQ: XLO) - Q2 2025 snapshot Key points & statistics * Cash and cash equivalents: $121,551 (thousands) as of June 30, 2025. * Total assets: $133,813; total liabilities: $126,744; stockholders' equity: $7,069 (all in thousands). * Collaboration & license revenue (Q2 20...